The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells

…, W Chen, EK Spicer, N Courtenay-Luck… - Cancer research, 2008 - AACR
We sought to determine whether nucleolin, a bcl-2 mRNA-binding protein, has a role in the
regulation of bcl-2 mRNA stability in MCF-7 and MDA-MB-231 breast cancer cells. …

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

…, V Jamieson, N Courtenay-Luck… - Blood, The Journal …, 2016 - ashpublications.org
We report the results of a multicenter phase 1 dose-escalation study of the selective Bruton
tyrosine kinase (BTK) inhibitor ONO/GS-4059 in 90 patients with relapsed/refractory B-cell …

Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells

…, L Wang, V Sridharan, W Chen, N Courtenay-Luck… - Molecular …, 2009 - ASPET
AS1411 is a DNA aptamer that is in phase II clinical trials for relapsed or refractory acute
myeloid leukemia and for renal cell carcinoma. AS1411 binds to nucleolin, a protein that is …

Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms

NS Courtenay-Luck, AA Epenetos, R Moore, M Larche… - Cancer research, 1986 - AACR
Human anti-mouse immunoglobulin immune responses were studied in ten patients, eight
with ovarian cancer and two with grade IV gliomas, diagnosed and treated with radiolabeled ( …

Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide

…, G Sirmalis, A Stuttle, NS Courtenay-Luck… - European journal of …, 1998 - Springer
Integrins are cell-surface glycoproteins found in different forms on all cells except erythrocytes.
Integrins bind to cell adhesion molecules and to proteins found in the extracellular matrix. …

[PDF][PDF] Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental …

…, A Hemingway, N Courtenay-Luck… - Journal of nuclear …, 1989 - Soc Nuclear Med
Twenty-seven patients with brain glioma were scanned using 1@ l-labeledmonoclonal
antibodies against epidermal growth factor receptor (EGFR1) or placental alkaline phosphatase (…

Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and …

C Kosmas, D Snook, CS Gooden, NS Courtenay-Luck… - Cancer Research, 1992 - AACR
The development of stable immunoconjugates by the advent of macrocyclic metal chelating
agents (DOTA) has enabled us to study the ability of 111 In-DOTA-labeled monoclonal …

huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor …

…, G Qin, R Verma, N Courtenay-Luck… - Cancer Immunology …, 2007 - Springer
IL-12 is a cytokine which showed anti-tumor effects in clinical trials, but also produced
serious toxicity. We describe a fusion protein, huBC1-IL12, designed to achieve an improved …

Cyclic AMP: a mitogenic signal for Swiss 3T3 cells.

…, G Strang, N Courtenay-Luck - Proceedings of the …, 1981 - National Acad Sciences
Addition of cholera toxin (100 ng/ml) to quiescent cultures of Swiss 3T3 cells acts synergistically
with serum (2-4%), insulin, phorbol esters, epidermal growth factor, and fibroblast-…

Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells

…, R Verma, M Pignatelli, MA Ritter, NS Courtenay-Luck… - Cancer research, 2000 - AACR
ED-B fibronectin (FN) is a FN isoform derived from alternative splicing of the primary transcript
of a single gene. Its expression on tumor stroma and neoformed tumor vasculature and its …